HEADER DE NOVO PROTEIN 20-DEC-19 6VC1 TITLE OCTREOTIDE OXALATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: OCTREOTIDE; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: UNIDENTIFIED; SOURCE 4 ORGANISM_TAXID: 32644 KEYWDS OCTREOTIDE, DE NOVO PROTEIN; SOMATOSTATIN-14 ANALOGUE, DE NOVO KEYWDS 2 PROTEIN EXPDTA POWDER DIFFRACTION AUTHOR M.SPILIOPOULOU,F.KARAVASSILI,D.TRIANDAFILLIDIS,A.VALMAS,C.KOSINAS, AUTHOR 2 S.FILI,K.BARLOS,K.K.BARLOS,M.MORIN,M.REINLE-SCHMITT,F.GOZZO, AUTHOR 3 I.MARGIOLAKI REVDAT 3 06-NOV-24 6VC1 1 REMARK REVDAT 2 19-MAY-21 6VC1 1 JRNL REVDAT 1 23-DEC-20 6VC1 0 JRNL AUTH M.SPILIOPOULOU,F.KARAVASSILI,D.P.TRIANDAFILLIDIS,A.VALMAS, JRNL AUTH 2 S.FILI,C.KOSINAS,K.BARLOS,K.K.BARLOS,M.MORIN, JRNL AUTH 3 M.L.REINLE-SCHMITT,F.GOZZO,I.MARGIOLAKI JRNL TITL NEW PERSPECTIVES IN MACROMOLECULAR POWDER DIFFRACTION USING JRNL TITL 2 SINGLE-PHOTON-COUNTING STRIP DETECTORS: HIGH-RESOLUTION JRNL TITL 3 STRUCTURE OF THE PHARMACEUTICAL PEPTIDE OCTREOTIDE. JRNL REF ACTA CRYSTALLOGR.,SECT.A V. 77 186 2021 JRNL REFN ESSN 2053-2733 JRNL PMID 33944797 JRNL DOI 10.1107/S2053273321001698 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 4 REMARK 4 6VC1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1000246043. REMARK 250 REMARK 250 REFINEMENT. REMARK 250 PROGRAM : GSAS REMARK 250 AUTHORS : LARSON & VON DREELE REMARK 250 DATA USED IN REFINEMENT REMARK 250 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 250 RESOLUTION RANGE LOW (ANGSTROMS) : 74.45 REMARK 250 POWDER DIFFRACTION DATA. REMARK 250 FIT TO DATA USED IN REFINEMENT REMARK 250 NUMBER OF POWDER PATTERNS : 2 REMARK 250 PROFILE R VALUES (%) : 6.29 5.61 REMARK 250 WEIGHTED PROFILE R VALUES (%) : 8.44 7.40 REMARK 250 F**2 R VALUES (%) : 45.95 43.29 REMARK 250 NUMBERS OF POWDER PATTERN POINTS : 30815 29392 REMARK 250 NUMBERS OF REFLECTIONS : 4926 4876 REMARK 250 TOTAL NUMBER OF POWDER POINTS : 60207 REMARK 250 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 250 PROTEIN ATOMS : REMARK 250 NUCLEIC ACID ATOMS : REMARK 250 HETEROGEN ATOMS : REMARK 250 SOLVENT ATOMS : REMARK 250 MODEL REFINEMENT. REMARK 250 NUMBER OF LEAST-SQUARES PARAMETERS : 48 REMARK 250 NUMBER OF RESTRAINTS : 968 REMARK 250 LEAST-SQUARES MATRIX BAND WIDTH : 48 REMARK 250 MARQUARDT COEFFICIENT : 8.49 REMARK 250 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. NUMBER. REMARK 250 INTERATOMIC DISTANCES (A) :0.014 300 REMARK 250 BOND ANGLES (DEG) : 1.61 375 REMARK 250 DISTANCES FROM RESTRAINT PLANES (A) :0.015 108 REMARK 250 TORSION ANGLE RESTRAINTS (E) : 0.53 45 REMARK 250 CHIRAL VOLUMES (A**3) :0.106 30 REMARK 250 TORSION PSEUDOPOTENTIAL RESTRAINTS (E) : 4.22 23 REMARK 250 ANTI-BUMPING DISTANCE RESTRAINTS (A) :0.029 50 REMARK 250 HYDROGEN BOND DISTANCE RESTRAINTS (A) :0.345 37 REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OXL A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide DPN B 1 and CYS B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PHE B 3 and DTR B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide DTR B 4 and LYS B 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide DPN C 1 and CYS C 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PHE C 3 and DTR C 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide DTR C 4 and LYS C 5 DBREF 6VC1 A 1 8 PDB 6VC1 6VC1 1 8 DBREF 6VC1 B 1 8 PDB 6VC1 6VC1 1 8 DBREF 6VC1 C 1 8 PDB 6VC1 6VC1 1 8 SEQRES 1 A 8 DPN CYS PHE DTR LYS THR CYS THR SEQRES 1 B 8 DPN CYS PHE DTR LYS THR CYS THR SEQRES 1 C 8 DPN CYS PHE DTR LYS THR CYS THR HET DPN A 1 11 HET DTR A 4 14 HET DPN B 1 11 HET DTR B 4 14 HET DPN C 1 11 HET DTR C 4 14 HET OXL A 101 6 HETNAM DPN D-PHENYLALANINE HETNAM DTR D-TRYPTOPHAN HETNAM OXL OXALATE ION FORMUL 1 DPN 3(C9 H11 N O2) FORMUL 1 DTR 3(C11 H12 N2 O2) FORMUL 4 OXL C2 O4 2- FORMUL 5 HOH *31(H2 O) HELIX 1 AA1 LYS B 5 CYS B 7 5 3 HELIX 2 AA2 PHE C 3 THR C 8 5 6 SHEET 1 AA1 3 CYS A 2 PHE A 3 0 SHEET 2 AA1 3 THR A 6 CYS A 7 -1 O THR A 6 N PHE A 3 SHEET 3 AA1 3 CYS B 2 PHE B 3 -1 O CYS B 2 N CYS A 7 SSBOND 1 CYS A 2 CYS A 7 1555 1555 1.99 SSBOND 2 CYS B 2 CYS B 7 1555 1555 2.05 SSBOND 3 CYS C 2 CYS C 7 1555 1555 2.03 LINK C DPN A 1 N CYS A 2 1555 1555 1.33 LINK C PHE A 3 N DTR A 4 1555 1555 1.33 LINK C DTR A 4 N LYS A 5 1555 1555 1.33 LINK C DPN B 1 N CYS B 2 1555 1555 1.32 LINK C PHE B 3 N DTR B 4 1555 1555 1.32 LINK C DTR B 4 N LYS B 5 1555 1555 1.32 LINK C DPN C 1 N CYS C 2 1555 1555 1.32 LINK C PHE C 3 N DTR C 4 1555 1555 1.33 LINK C DTR C 4 N LYS C 5 1555 1555 1.33 SITE 1 AC1 6 PHE A 3 THR A 8 HOH A 202 HOH A 203 SITE 2 AC1 6 HOH A 205 HOH A 206 SITE 1 AC2 7 THR A 6 CYS A 7 THR A 8 PHE B 3 SITE 2 AC2 7 THR B 6 CYS B 7 HOH B 102 SITE 1 AC3 9 LYS A 5 THR A 6 CYS B 2 LYS B 5 SITE 2 AC3 9 THR B 6 CYS B 7 HOH B 104 PHE C 3 SITE 3 AC3 9 DTR C 4 SITE 1 AC4 8 LYS A 5 PHE B 3 THR B 6 CYS B 7 SITE 2 AC4 8 THR B 8 HOH B 104 PHE C 3 DTR C 4 SITE 1 AC5 8 CYS A 2 PHE A 3 DTR A 4 HOH A 203 SITE 2 AC5 8 PHE C 3 CYS C 7 HOH C 105 HOH C 107 SITE 1 AC6 7 DTR A 4 LYS A 5 DTR B 4 CYS C 2 SITE 2 AC6 7 LYS C 5 THR C 6 CYS C 7 SITE 1 AC7 9 DTR A 4 LYS A 5 DTR B 4 PHE C 3 SITE 2 AC7 9 THR C 6 CYS C 7 THR C 8 HOH C 101 SITE 3 AC7 9 HOH C 104 CRYST1 18.529 30.288 39.731 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.053970 0.000000 0.000000 0.00000 SCALE2 0.000000 0.033016 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025169 0.00000 HETATM 1 N DPN A 1 -0.913 19.629 16.306 1.00 14.31 N HETATM 2 CA DPN A 1 -0.288 20.382 15.223 1.00 14.31 C HETATM 3 C DPN A 1 -0.794 19.843 13.869 1.00 14.31 C HETATM 4 O DPN A 1 -1.836 20.178 13.366 1.00 14.31 O HETATM 5 CB DPN A 1 -0.642 21.894 15.362 1.00 14.31 C HETATM 6 CG DPN A 1 -0.008 22.843 14.333 1.00 14.31 C HETATM 7 CD1 DPN A 1 -0.634 23.040 13.097 1.00 14.31 C HETATM 8 CD2 DPN A 1 1.218 23.462 14.590 1.00 14.31 C HETATM 9 CE1 DPN A 1 -0.032 23.831 12.124 1.00 14.31 C HETATM 10 CE2 DPN A 1 1.815 24.263 13.619 1.00 14.31 C HETATM 11 CZ DPN A 1 1.191 24.445 12.387 1.00 14.31 C